(Q33727750)

28 July 2017

Angiotensin type 2 receptor actions contribute to angiotensin type 1 receptor blocker effects on kidney fibrosis (English)

1 reference

28 July 2017

Takashi Naito

1

1 reference

28 July 2017

Li-Jun Ma

2

1 reference

28 July 2017

Haichun Yang

3

1 reference

28 July 2017

Yiqin Zuo

4

1 reference

28 July 2017

Yiwei Tang

5

1 reference

28 July 2017

Jee Young Han

6

1 reference

28 July 2017

Valentina Kon

7

1 reference

28 July 2017

Agnes B Fogo

8

1 reference

28 July 2017

30 December 2009

1 reference

American Journal of Physiology - Renal Physiology

28 July 2017

1 reference

28 July 2017

298

1 reference

28 July 2017

F683-91

1 reference

28 July 2017

3

1 reference

Glomerular type 1 angiotensin receptors augment kidney injury and inflammation in murine autoimmune nephritis

28 July 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2838584

Regression of glomerulosclerosis in subtotally nephrectomized rats: effects of monotherapy with losartan, spironolactone, and their combination.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2838584

Plasminogen activator inhibitor-1 in chronic kidney disease: evidence and mechanisms of action

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2838584

MAPK/AP-1-dependent regulation of PAI-1 gene expression by TGF-beta in rat mesangial cells

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2838584

Update on the role of the AT2 receptor

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2838584

Persistent proteinuria up-regulates angiotensin II type 2 receptor and induces apoptosis in proximal tubular cells

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2838584

The plasminogen activator inhibitor-1 gene is induced by cell adhesion through the MEK/ERK pathway

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2838584

A mutant, noninhibitory plasminogen activator inhibitor type 1 decreases matrix accumulation in experimental glomerulonephritis

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2838584

Angiotensin II subtype 2 receptor activation inhibits insulin-induced phosphoinositide 3-kinase and Akt and induces apoptosis in PC12W cells.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2838584

Regulation of vascular proteoglycan synthesis by angiotensin II type 1 and type 2 receptors

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2838584

Renal fibrosis and the renin-angiotensin system.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2838584

Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2838584

AT(1) and AT(2) receptors in the kidney: role in disease and treatment.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2838584

Plasminogen activator inhibitor-1 expression is regulated by the angiotensin type 1 receptor in vivo

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2838584

The role of angiotensin II and plasminogen activator inhibitor-1 in progressive glomerulosclerosis

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2838584

Natriuretic factors and nitric oxide suppress plasminogen activator inhibitor-1 expression in vascular smooth muscle cells. Role of cGMP in the regulation of the plasminogen system

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2838584

Angiotensin type 2 receptor dephosphorylates Bcl-2 by activating mitogen-activated protein kinase phosphatase-1 and induces apoptosis

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2838584

The subtype 2 (AT2) angiotensin receptor mediates renal production of nitric oxide in conscious rats

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2838584

Glomeruli and blood pressure. Less of one, more the other?

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2838584

Therapeutic advantage of converting enzyme inhibitors in arresting progressive renal disease associated with systemic hypertension in the rat

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2838584

Control of glomerular hypertension limits glomerular injury in rats with reduced renal mass

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2838584

Reversal of Glomerulosclerosis after High-Dose Enalapril Treatment in Subtotally Nephrectomized Rats

21 June 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00503.2009

Angiotensin II type 2 receptor deficiency aggravates renal injury and reduces survival in chronic kidney disease in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00503.2009

Angiotensin type 2 receptor antagonism confers renal protection in a rat model of progressive renal injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00503.2009

Angiotensin type 2 receptor is expressed in the adult rat kidney and promotes cellular proliferation and apoptosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00503.2009

Angiotensin II, via AT1 and AT2 receptors and NF-kappaB pathway, regulates the inflammatory response in unilateral ureteral obstruction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00503.2009

Attenuation of cuff-induced neointimal formation by overexpression of angiotensin II type 2 receptor-interacting protein 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00503.2009

Overexpression of angiotensin type 2 receptor ameliorates glomerular injury in a mouse remnant kidney model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00503.2009

Stimulation of cyclic GMP production via AT2 and B2 receptors in the pressure-overloaded aorta after banding

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00503.2009

Angiotensin AT2 receptor contributes to cardiovascular remodelling of aged rats during chronic AT1 receptor blockade.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00503.2009

Angiotensin II stimulates the synthesis of vascular endothelial growth factor through the p38 mitogen activated protein kinase pathway in cultured mouse podocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00503.2009

Effect of angiotensin II type 2 receptor on tyrosine kinase Pyk2 and c-Jun NH2-terminal kinase via SHP-1 tyrosine phosphatase activity: evidence from vascular-targeted transgenic mice of AT2 receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00503.2009

Angiotensin II type 2 receptors stimulate collagen synthesis in cultured vascular smooth muscle cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00503.2009

Increased renal vascular endothelial growth factor and angiopoietins by angiotensin II infusion is mediated by both AT1 and AT2 receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00503.2009

Angiotensin II type 2 receptor inhibits epidermal growth factor receptor transactivation by increasing association of SHP-1 tyrosine phosphatase

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00503.2009

Critical role of Rho-kinase and MEK/ERK pathways for angiotensin II-induced plasminogen activator inhibitor type-1 gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00503.2009

Angiotensin II-dependent induction of AT(2) receptor expression after renal ablation

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00503.2009

Effect of blood pressure lowering and antihypertensive drug class on progression of hypertensive kidney disease: results from the AASK trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00503.2009

Mitogen-activated Protein Kinases and Activator Protein 1 Are Required for Proliferation and Cardiomyocyte Differentiation of P19 Embryonal Carcinoma Cells

21 January 2018

1 reference

12 December 2020

Cardiac angiotensin II type 2 receptor activates the kinin/NO system and inhibits fibrosis

1 reference

12 December 2020

Accelerated fibrosis and collagen deposition develop in the renal interstitium of angiotensin type 2 receptor null mutant mice during ureteral obstruction

1 reference

12 December 2020

Role of AT1 and AT2 receptors in regulation of MAPKs and MKP-1 by ANG II in adult cardiac myocytes

1 reference

12 December 2020

Angiotensin II modulates cellular functions of podocytes

1 reference

12 December 2020

Effect of AT2 receptor blockade on the pathogenesis of renal fibrosis

1 reference

12 December 2020

Regression of glomerulosclerosis with high-dose angiotensin inhibition is linked to decreased plasminogen activator inhibitor-1

1 reference

12 December 2020

Angiotensin type 1 receptor blocker restores podocyte potential to promote glomerular endothelial cell growth

1 reference

12 December 2020

PPAR-gamma agonist protects podocytes from injury

1 reference

12 December 2020

Inhibitory effect of angiotensin II type 2 receptor on coronary arterial remodeling after aortic banding in mice

1 reference

12 December 2020

Regression of sclerosis in aging by an angiotensin inhibition-induced decrease in PAI-1

1 reference

12 December 2020

Progression and potential regression of glomerulosclerosis

1 reference

12 December 2020

Angiotensin II type 2 receptor is essential for left ventricular hypertrophy and cardiac fibrosis in chronic angiotensin II-induced hypertension

1 reference

12 December 2020

10.1152/AJPRENAL.00503.2009

Identifiers

DOI

1 reference

28 July 2017

1 reference

28 July 2017

1 reference